menu

Medical Program: Monitoring Adjuvant Chemotherapy in Elderly Women with Triple Negative Breast Cancer

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Monitoring Adjuvant Chemotherapy in Elderly Women with Triple Negative Breast Cancer

close
Monitoring Adjuvant Chemotherapy in Elderly Women with Triple Negative Breast Cancer
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Despite the increasing number of elderly patients diagnosed with breast cancer, few clinical trials focus on this age group. That’s why Dr. Slavica Janeva's team focused on the impacts of adjuvant chemotherapy on survival rates in this patient population, the results of which may change clinical practice paradigms moving forward, as he discusses with Dr. Matt Birnholz.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Sponsored by

  • Overview

    Despite the increasing number of elderly patients diagnosed with breast cancer, few clinical trials focus on this age group. That’s why Dr. Slavica Janeva's team focused on the impacts of adjuvant chemotherapy on survival rates in this patient population, the results of which may change clinical practice paradigms moving forward, as he discusses with Dr. Matt Birnholz.

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 8/3/20